| Literature DB >> 26585824 |
David Fernando Plaza1, Stefanie Sofia Schmieder1, Anna Lipzen2, Erika Lindquist2, Markus Künzler3.
Abstract
The dung of herbivores, the natural habitat of the model mushroom Coprinopsis cinerea, is a nutrient-rich but also very competitive environment for a saprophytic fungus. We showed previously that C. cinerea expresses constitutive, tissue-specific armories against antagonists such as animal predators and bacterial competitors. In order to dissect the inducible armories against such antagonists, we sequenced the poly(A)-positive transcriptome of C. cinerea vegetative mycelium upon challenge with fungivorous and bacterivorous nematodes, Gram-negative and Gram-positive bacteria and mechanical damage. As a response to the fungivorous nematode Aphelenchus avenae, C. cinerea was found to specifically induce the transcription of several genes encoding previously characterized nematotoxic lectins. In addition, a previously not characterized gene encoding a cytoplasmic protein with several predicted Ricin B-fold domains, was found to be strongly upregulated under this condition. Functional analysis of the recombinant protein revealed a high toxicity toward the bacterivorous nematode Caenorhabditis elegans. Challenge of the mycelium with A. avenae also lead to the induction of several genes encoding putative antibacterial proteins. Some of these genes were also induced upon challenge of the mycelium with the bacteria Escherichia coli and Bacillus subtilis. These results suggest that fungi have the ability to induce specific innate defense responses similar to plants and animals.Entities:
Keywords: CCTX2; RNA sequencing; basidiomycete; fungal defense; transcriptomics
Mesh:
Substances:
Year: 2015 PMID: 26585824 PMCID: PMC4704728 DOI: 10.1534/g3.115.023069
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
General features of Coprinopsis cinerea mycelia exposed to different biotic and abiotic stress conditions
| Mapped Reads (Sense + Antisense) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Treatment | Replicate 1 | % of Total | Replicate 2 | % of Total | Replicate 3 | % of Total | Total Mapped | Mean % of Loci Transcribed |
| O7 + PBS | 3.31E+07 | 81.1 | 4.14E+07 | 78.6 | 4.54E+07 | 83.1 | 1.20E+08 | 82.3 |
| O7 + | 2.51E+07 | 53.7 | 4.90E+07 | 82.6 | 3.87E+07 | 75.5 | 1.13E+08 | 82.1 |
| O7 + | 3.14E+07 | 77.1 | 5.28E+07 | 78.9 | 4.31E+07 | 83.0 | 1.27E+08 | 82.4 |
| O7 + mechanical damage | 2.40E+07 | 80.5 | 5.14E+07 | 80.5 | 4.08E+07 | 82.8 | 1.16E+08 | 82.6 |
| O7 + | 5.53E+07 | 79.4 | 4.77E+07 | 79.5 | 5.09E+07 | 82.0 | 1.54E+08 | 82.5 |
| O7 + | 4.86E+07 | 81.0 | 3.78E+07 | 83.1 | 3.63E+07 | 83.0 | 1.23E+08 | 83.3 |
| Total no. of mapped reads | 7.53E+08 | |||||||
| Approximate read length | 100 bases | |||||||
| Approximate total output | 75 Gigabases | |||||||
Biological replicates.
Percentage of the total number of sequenced reads that was mapped to the reference genome.
Total number of mapped reads: 7.53E+08; Approximate read length: 100 bases; Approximate total sequence output: 75 Gbases.
Figure 1Challenge of Coprinopsis cinerea vegetative mycelium by Aphelenchus avenae predation and bacterial cocultivation induce treatment-specific defense responses at the transcriptional level. (A) Volcano plots showing the genome-wide differential expression analysis of Coprinopsis cinerea O7 challenged with the fungivorous nematode A. avenae (O7Aa), the bacterivorous nematode Caenorhabditis elegans N2 (O7Ce), Escherichia coli Nissle 1917 (O7Ec) and Bacillus subtilis 168 (O7Bs) relative to the application of buffer as negative control (NC). As additional treatment, supposedly mimicking the mechanical damage of hyphae inflicted by fungivore feeding, Coprinopsis cinerea vegetative mycelium was repeatedly cut with a scalpel (O7MD). Genes showing log2 (treatment/NC) ≥ 2 or ≤ –2, and –log10 (Welch's t-test-derived p-values calculated from three biological replicates) ≥ 1.3 were considered to be significantly upregulated (orange boxes) or downregulated (gray boxes). (B) Venn’s diagram computed for genes significantly upregulated by the fungivorous nematode A. avenae (Aa), the bacterivorous nematode Caenorhabditis elegans (Ce), the scalpel-inflicted hyphal damage (MD), E. coli (Ec) or B. subtilis (Bs). (C) Venn’s diagram computed for genes significantly downregulated by A. avenae (Aa), Caenorhabditis elegans (Ce), the scalpel-inflicted hyphal damage (MD), E. coli (Ec) or B. subtilis (Bs).
Coprinopsis cinerea Okayama7 protein-encoding genes significantly upregulated in response to the applied treatments
| Treatment/Locus | PSI-Blast/PHYRE2 Prediction | SignalP | TMHMM | Pfam Cross-Reference | MD/NC | ||||
|---|---|---|---|---|---|---|---|---|---|
| CC1G_01501 | CBM-containing secreted protein | Y | 0 | 4.1 | — | — | — | — | |
| CC1G_02104 | Peroxidase | Y | 0 | PF11895; PF00141 | 5.4 | — | — | — | — |
| CC1G_02355 | Hypothetical secreted protein | Y | 0 | 4.4 | — | — | — | — | |
| CC1G_02622 | Ankyrin-repeat protein | N | 0 | PF12796 | 5.2 | — | — | — | — |
| CC1G_03076 | GH24 lysozyme | Y | 0 | PF00959 | 5.2 | — | — | — | — |
| CC1G_04169 | WSC domain-containing secreted protein | Y | 0 | PF00734; PF09362 | 5.2 | — | — | — | — |
| CC1G_05003 | CGL1 galectin | N | 0 | PF00337 | 5 | — | — | — | — |
| CC1G_05005 | CGL2 galectin | N | 0 | PF00337 | 4.1 | — | — | — | — |
| CC1G_05809 | Glycosyl hydrolase family 18 protein | Y | 0 | 5.8 | — | — | — | — | |
| CC1G_06698 | RTA1-like protein | N | 7 | PF04479 | 20.4 | — | — | — | — |
| CC1G_08057 | Wnt-like secreted protein | Y | 0 | 4.4 | — | — | — | — | |
| CC1G_08593 | Hypothetical secreted protein | Y | 0 | 6.2 | — | — | — | — | |
| CC1G_09966 | NmrA-family protein | N | 0 | PF05368 | 4.9 | — | — | — | — |
| CC1G_10077 | Ricin B-fold domain-containing protein | N | 0 | PF14200 | 4.9 | — | — | — | — |
| CC1G_10726 | Hypothetical secreted protein | Y | 0 | 28.4 | — | — | — | — | |
| CC1G_11792 | Hypothetical membrane protein | N | 1 | 5 | — | — | — | — | |
| CC1G_11847 | Defensin-related protein | Y | 0 | 9.4 | — | — | — | — | |
| CC1G_12246 | Hypothetical transmembrane protein | N | 7 | 6.8 | — | — | — | — | |
| CC1G_14365 | Hypothetical protein | N | 0 | 6.1 | — | — | — | — | |
| CC1G_14558 | Hypothetical protein | N | 0 | 5.6 | — | — | — | — | |
| CC1G_04017 | Hypothetical protein | N | 0 | — | 5.8 | — | — | — | |
| Mechanical damage (MD) | |||||||||
| CC1G_02583 | Membrane-anchored glycosylhydrolase | N | 1 | — | — | 6 | — | — | |
| CC1G_03098 | Ras-like GTPase | N | 0 | PF01926 | — | — | 4.8 | — | — |
| CC1G_03514 | Hypothetical protein | N | 0 | — | — | 4.3 | — | — | |
| CC1G_09359 | Hypothetical protein | N | 0 | — | — | 4.9 | — | — | |
| CC1G_10157 | Hypothetical protein | N | 0 | — | — | 5 | — | — | |
| CC1G_11387 | Cyclopropane-fatty-acyl-phospholipid synthase esynthase | N | 0 | PF02353 | — | — | 4.5 | — | — |
| CC1G_11620 | Hypothetical protein | N | 0 | — | — | 4.6 | — | — | |
| CC1G_12367 | Hypothetical transmembrane protein | N | 7 | — | — | 5.7 | — | — | |
| CC1G_15356 | Hypothetical protein | N | 0 | — | — | 5.9 | — | — | |
| CC1G_00122 | Cytochrome P450 | N | 0 | PF00067 | — | — | — | 4.1 | — |
| CC1G_01525 | Transaldolase | N | 0 | PF00923 | — | — | — | 4.5 | — |
| CC1G_02052 | YCII-related domain protein | N | 0 | PF03795 | — | — | — | 5.6 | — |
| CC1G_02062 | N-alpha-acetyltransferase 60-like | N | 0 | PF00583 | — | — | — | 9.4 | — |
| CC1G_02166 | Hypothetical membrane protein | N | 1 | — | — | — | 9.3 | — | |
| CC1G_02345 | Malate synthase | N | 0 | PF01274 | — | — | — | 5.7 | — |
| CC1G_02382 | Lipolytic enzyme | Y | 0 | PF00657 | — | — | — | 5.4 | — |
| CC1G_02862 | Snoal-like polyketide cyclase family protein | Y | 0 | — | — | — | 6.5 | — | |
| CC1G_02908 | Alcohol dehydrogenase | N | 0 | PF08240; PF00107 | — | — | — | 4.8 | — |
| CC1G_03339 | Fasciclin-domain containing secreted protein | Y | 0 | PF02469 | — | — | — | 4.8 | — |
| CC1G_03442 | Endonuclease/exonuclease/phosphatase | Y | 0 | PF03372 | — | — | — | 5.1 | — |
| CC1G_03541 | Hypothetical secreted protein | Y | 0 | — | — | — | 16.7 | — | |
| CC1G_04927 | Hypothetical protein | N | 3 | — | — | — | 5.9 | — | |
| CC1G_05515 | FAD-dependent oxidoreductase | Y | 0 | PF01266 | — | — | — | 5.5 | — |
| CC1G_05607 | Ig-domain containing secreted protein | Y | 0 | — | — | — | 5.1 | — | |
| CC1G_05864 | LolT-1-like PLP-dependent aminotransferase | N | 0 | PF00266 | — | — | — | 7.1 | — |
| CC1G_05914 | Ammonium transporter | N | 11 | PF00909 | — | — | — | 32 | — |
| CC1G_06488 | Urea transporter | N | 15 | PF00474 | — | — | — | 5.5 | — |
| CC1G_06620 | Isocitrate lyase | N | 0 | PF00463 | — | — | — | 4.5 | — |
| CC1G_06972 | NAD(P)H-dependent dehydrogenase | N | 0 | PF07992 | — | — | — | 4.1 | — |
| CC1G_07061 | Hypothetical protein | N | 0 | — | — | — | 4.8 | — | |
| CC1G_07630 | MAPEG protein | N | 0 | PF01124 | — | — | — | 4.1 | — |
| CC1G_07735 | Mitochondrial carrier/telomere-binding protein | N | 0 | PF00153; PF10451 | — | — | — | 5 | — |
| CC1G_08094 | High affinity methionine permease | N | 12 | PF13520 | — | — | — | 6 | — |
| CC1G_08394 | Hypothetical protein | N | 0 | — | — | — | 8.5 | — | |
| CC1G_08758 | Hypothetical secreted protein | Y | 0 | — | — | — | 4.3 | — | |
| CC1G_08822 | WSC domain-containing protein | Y | 0 | PF01822 | — | — | — | 4.1 | — |
| CC1G_08888 | Acyl-coA carboxylate coA-transferase | N | 0 | PF13336; PF02550 | — | — | — | 9.1 | — |
| CC1G_11310 | Pria protein | Y | 0 | — | — | — | 5.6 | — | |
| CC1G_11374 | PLAC8-domain-containing protein | N | 0 | PF04749 | — | — | — | 4.3 | — |
| CC1G_11786 | Hypothetical transmembrane protein | N | 4 | — | — | — | 6.1 | — | |
| CC1G_12758 | Acyl-coA N-acyltransferase | N | 0 | PF13302 | — | — | — | 20.3 | — |
| CC1G_12964 | Citrate synthase | N | 0 | PF00285 | — | — | — | 4.1 | — |
| CC1G_12996 | Ricin B-fold domain-containing protein | Y | 0 | PF00652 | — | — | — | 4.3 | — |
| CC1G_13124 | Ammonium transporter | N | 9 | PF00909 | — | — | — | 7.9 | — |
| CC1G_13213 | Glycerophosphoryl diester phosphodiesterase | Y | 0 | PF03009 | — | — | — | 12.2 | — |
| CC1G_13246 | Hypothetical transmembrane protein | N | 5 | — | — | — | 6.2 | — | |
| CC1G_13826 | Hypothetical transmembrane protein | N | 4 | — | — | — | 7.4 | — | |
| CC1G_14125 | Mitochondrial carrier | N | 3 | PF00153 | — | — | — | 5.1 | — |
| CC1G_14829 | Glutathione-S-transferase | N | 0 | PF00043; PF13417 | — | — | — | 8.4 | — |
| CC1G_15187 | Hypothetical protein | N | 0 | — | — | — | 4 | — | |
| CC1G_15681 | Hypothetical protein | N | 0 | — | — | — | 8.3 | — | |
| CC1G_15703 | Cytochrome p450 | N | 0 | PF00067 | — | — | — | 4.7 | — |
| CC1G_08300 | Hydrophobin | N | 1 | — | — | — | 10.5 | — | |
| CC1G_03042 | GH24 lysozyme | Y | 0 | PF00959 | — | — | — | — | 5.6 |
| CC1G_05798 | CBM-containing secreted protein | Y | 0 | — | — | — | — | 4.2 | |
| CC1G_09605 | Hypothetical protein | N | 0 | — | — | — | — | 8.9 | |
| CC1G_10004 | Hypothetical secreted protein | Y | 0 | — | — | — | — | 5.1 | |
| CC1G_08311 | Monocarboxylate permease | N | 11 | PF07690 | — | — | — | — | 4.7 |
| CC1G_00718 | Hypothetical secreted protein | Y | 1 | — | — | — | 6.6 | 6.4 | |
| CC1G_05600 | Hypothetical secreted protein | Y | 0 | — | — | — | 10.9 | 11.7 | |
| CC1G_08056 | Wnt-like secreted protein | Y | 0 | — | — | — | 20.6 | 15.9 | |
| CC1G_08433 | Hypothetical protein | N | 0 | — | — | — | 42.8 | 11.1 | |
| CC1G_09365 | Triacylglycerol lipase | Y | 0 | PF01083 | — | — | — | 6.8 | 11.5 |
| CC1G_14477 | GH24 lysozyme | N | 0 | PF00959 | — | — | — | 6.9 | 6.2 |
| CC1G_02441 | Hypothetical protein | Y | 0 | 6.6 | — | — | 5.2 | — | |
| CC1G_04734 | Med17 domain-containing protein | Y | 0 | 4.5 | — | — | 5.7 | — | |
| CC1G_07582 | Hypothetical secreted protein | Y | 0 | 8.9 | — | — | 5.1 | — | |
| CC1G_09529 | Hypothetical secreted protein | Y | 0 | 5 | — | — | 5.7 | — | |
| CC1G_10384 | O-Methylsterigmatocystin oxidoreductase | N | 0 | PF00067 | 4.6 | — | — | 6.7 | — |
| CC1G_06684 | LysM domain-containing protein | Y | 0 | PF01476 | 4.2 | — | — | 15.4 | — |
| CC1G_02581 | Hypothetical membrane protein | Y | 2 | — | 8 | — | 31.1 | — | |
| CC1G_05472 | Wnt-like secreted protein | Y | 0 | 9 | — | — | — | 6.7 | |
| CC1G_03047 | GH24 lysozyme | N | 0 | PF00959 | 7 | — | — | — | 4.8 |
| CC1G_08818 | Hypothetical secreted protein | Y | 0 | — | 17.7 | — | — | 38.1 | |
| CC1G_13803 | Hypothetical protein | N | 0 | — | 7.2 | — | — | 12.7 | |
| CC1G_13818 | MFS general substrate transporter | Y | 9 | 9.1 | 5.4 | — | 16.1 | — | |
| MD+ | |||||||||
| CC1G_15139 | Metalloprotease | Y | 0 | PF05572 | — | — | 4 | 13.4 | |
| CC1G_01042 | PAP2 superfamily protein | Y | 0 | — | 21.7 | — | 42.9 | 35 | |
| CC1G_05219 | KapM protein | Y | 0 | — | 7.5 | — | 14.5 | 9.3 | |
As thresholds of significant differential expression, fold (treatment/negative control) ≥ 4 and Welch’s t-test p-value ≤ 0.05 (from three biological replicates per treatment) were used. Presence (Y) or absence (N) of secretion signal was computed with SignalP 4.1. Number of transmembrane helices was predicted using TMHMM v. 2.0 in the proteins encoded by differentially expressed genes. Pfam cross-reference IDs are shown when available.
Coprinopsis cinerea Okayama7 protein-encoding genes significantly downregulated in response to the applied treatments
| Treatment/Locus | PSI-Blast/PHYRE2 Prediction | SignalP | TMHMM | Pfam Cross-Reference | NC/ | NC/ | NC/MD | NC/ | NC/ |
|---|---|---|---|---|---|---|---|---|---|
| CC1G_09526 | Endoglucanase-4 | Y | 0 | PF03443 | 4.1 | — | — | — | — |
| CC1G_09644 | Alpha-galactosidase | N | 0 | 5.8 | — | — | — | — | |
| CC1G_13605 | Hypothetical protein | N | 0 | 20.5 | — | — | — | — | |
| CC1G_13985 | Hypothetical protein | N | 0 | 6.7 | — | — | — | — | |
| CC1G_14464 | Reverse transcriptase/ribonuclease H | N | 0 | 6.2 | — | — | — | — | |
| CC1G_02106 | Hypothetical protein | Y | 0 | — | 6.7 | — | — | — | |
| CC1G_09458 | Extracellular tungstate binding | N | 0 | — | 4.1 | — | — | — | |
| CC1G_13558 | Hypothetical protein | Y | 0 | — | 5.1 | — | — | — | |
| CC1G_15088 | Hypothetical protein | N | 0 | — | 5.4 | — | — | — | |
| Mechanical damage (MD) | |||||||||
| CC1G_08269 | Hypothetical protein | Y | 0 | PF14273 | — | — | 4.6 | — | — |
| CC1G_08983 | Hypothetical protein | N | 7 | — | — | 6.7 | — | — | |
| CC1G_01035 | Hypothetical protein | N | 0 | — | — | — | 8.8 | — | |
| CC1G_01577 | Glycosyl hydrolase family 62 protein | Y | 0 | PF00734; PF03664 | — | — | — | 6.7 | — |
| CC1G_01879 | RNA recognition motif 2 partial | N | 0 | PF04059 | — | — | — | 4.1 | — |
| CC1G_02999 | Hypothetical protein | N | 0 | — | — | — | 4.2 | — | |
| CC1G_06017 | Tyrosinase central domain-containing protein | Y | 0 | PF00264 | — | — | — | 5.3 | — |
| CC1G_08259 | Leucine-rich repeat domain protein | N | 0 | PF12937 | — | — | — | 16.5 | — |
| CC1G_10148 | Hypothetical protein | N | 0 | — | — | — | 4.1 | — | |
| CC1G_10470 | Tyrosinase central domain-containing protein | Y | 0 | PF00264 | — | — | — | 8 | — |
| CC1G_10494 | Hypothetical protein | N | 5 | — | — | — | 4.7 | — | |
| CC1G_11188 | ycaC protein | N | 2 | PF00857 | — | — | — | 8.1 | — |
| CC1G_11580 | Hypothetical protein | N | 0 | — | — | — | 4.5 | — | |
| CC1G_12408 | Hypothetical protein | N | 0 | — | — | — | 4.2 | — | |
| CC1G_12509 | Galactose mutarotase-like protein | N | 0 | — | — | — | 4.4 | — | |
| CC1G_14013 | Cytochrome P450 | N | 1 | PF00067 | — | — | — | 4.5 | — |
| CC1G_14014 | O-Methylsterigmatocystin oxidoreductase | N | 0 | PF00067 | — | — | — | 4.6 | — |
| CC1G_14164 | AlphaN-acetylglucosamine transferase | N | 1 | — | — | — | 4.8 | — | |
| CC1G_01487 | Hypothetical protein | N | 0 | — | — | — | — | 6.9 | |
| CC1G_04915 | Hypothetical protein | N | 4 | — | — | — | — | 9 | |
| CC1G_05337 | Hypothetical protein | N | 7 | — | — | — | — | 6.4 | |
| CC1G_05968 | Hypothetical protein | N | 1 | — | — | — | — | 5.6 | |
| CC1G_08393 | Hypothetical protein | Y | 1 | — | — | — | — | 6.2 | |
| CC1G_14873 | Hypothetical protein | N | 0 | — | — | — | — | 4.4 | |
| CC1G_03158 | Hypothetical protein | Y | 3 | — | — | — | 5.9 | 7.4 | |
| CC1G_09799 | AgaK1 protein kinase | N | 0 | PF00069 | — | — | — | 5.9 | 7.1 |
| CC1G_10006 | Tyrosinase | N | 0 | PF00264 | — | — | — | 4.3 | 4.1 |
| CC1G_06907 | WD40 domain-containing protein | N | 1 | 5.8 | — | — | 6.8 | — | |
| CC1G_15644 | Hypothetical protein | Y | 0 | 10.2 | — | — | 13.6 | — | |
| CC1G_15616 | Extracellular tungstate binding | N | 0 | 4.9 | — | — | — | 6.2 | |
As thresholds of significant differential expression, fold (negative control/treatment) ≥ 4 and Welch’s t-test p-value ≤ 0.05 (from three biological replicates per treatment) were used. Presence (Y) or absence (N) of secretion signal was computed with SignalP 4.1. Number of transmembrane helices was predicted using TMHMM v. 2.0 in the proteins encoded by differentially expressed genes. Pfam cross-reference IDs are shown when available.
Figure 2CC1G_10077-encoded CCTX2 is nematotoxic. (A) Schematic domain representation of CCTX2 predicting two Ricin-type beta-trefoil domains potentially involved in carbohydrate binding. (B) Expression of soluble CCTX2 in E. coli. The cDNA of CC1G_10077 was cloned, and CCTX2 was expressed in the cytoplasm of E. coli BL21(DE3). Extracts of uninduced (UI) and (I) cells, as well as soluble proteins from induced cells (SP), were run on SDS-PAGE and stained with Coomassie Brilliant Blue. The predicted molecular weight of CCTX2 is 89 kDa. (C) Nematotoxicity of CCTX2. CCTX2-expressing bacteria and control bacteria containing ’empty’ vector (EV), or expressing the previously characterized nematotoxic lectin CGL2, were fed for 48 hr to L1 larvae of Caenorhabditis elegans N2 in order to assess the toxicity of CCTX2 toward nematodes. A Welch’s t-test was computed to test the significance of the differences observed between treatments and the ’empty’ vector control. ***p-value ≤ 0.001. Bars represent the standard deviation calculated for four biological replicates. (D) Phase contrast micrographs of Caenorhabditis elegans N2 fed with E. coli BL21 containing ’empty’ vector (EV), or E. coli expressing CGL2 or CCTX2.